Clinical Trial: SSGJ-707 in Advanced Non-Small Cell Lung Cancer

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06980272) titled 'SSGJ-707 in Advanced Non-Small Cell Lung Cancer' on May 12.

Brief Summary: This trial is a Phase III study. All patients are stage IIIB/C (unsuitable for radical therapy) or IV non-small cell lung cancer(NSCLC), Eastern Cooperative Oncology Group (ECOG) performance status 0-1. The purpose of this study is to evaluate the efficacy and safety of SSGJ-707 comparing Pembrolizumab in subjects with advanced NSCLC whose tumors have a programmed cell death-ligand 1 (PD-L1) Tumor Proportion Score (TPS) greater than or equal to 1%.

Study Start Date: June 25

Study Type: INTERVENTIONAL

Condition: Advanced Non-Small Cell Lung Cancer

Interven...